235 related articles for article (PubMed ID: 28863192)
1. E2/ER β inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling.
Tsai CY; Kuo WW; Shibu MA; Lin YM; Liu CN; Chen YH; Day CH; Shen CY; Viswanadha VP; Huang CY
PLoS One; 2017; 12(9):e0184153. PubMed ID: 28863192
[TBL] [Abstract][Full Text] [Related]
2. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
3. E2/ER β Enhances Calcineurin Protein Degradation and PI3K/Akt/MDM2 Signal Transduction to Inhibit ISO-Induced Myocardial Cell Apoptosis.
Lin KH; Kuo WW; Shibu MA; Day CH; Hsieh YL; Chung LC; Chen RJ; Wen SY; Viswanadha VP; Huang CY
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28441761
[TBL] [Abstract][Full Text] [Related]
4. 17β-Estradiol and/or estrogen receptor alpha signaling blocks protein phosphatase 1 mediated ISO induced cardiac hypertrophy.
Fang HY; Hung MY; Lin YM; Pandey S; Chang CC; Lin KH; Shen CY; Viswanadha VP; Kuo WW; Huang CY
PLoS One; 2018; 13(5):e0196569. PubMed ID: 29723269
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
[TBL] [Abstract][Full Text] [Related]
6. Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3.
Zhou X; Zhang Q; Zhao T; Bai X; Yuan W; Wu Y; Liu D; Li S; Ju J; Chege Gitau S; Chu W; Xu C; Lu Y
Eur J Pharmacol; 2014 Jul; 735():202-10. PubMed ID: 24769415
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes.
Xiao L; Coutu P; Villeneuve LR; Tadevosyan A; Maguy A; Le Bouter S; Allen BG; Nattel S
Circ Res; 2008 Sep; 103(7):733-42. PubMed ID: 18723449
[TBL] [Abstract][Full Text] [Related]
8. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
9. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
[TBL] [Abstract][Full Text] [Related]
10. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
[TBL] [Abstract][Full Text] [Related]
11. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.
Kato T; Sano M; Miyoshi S; Sato T; Hakuno D; Ishida H; Kinoshita-Nakazawa H; Fukuda K; Ogawa S
Circ Res; 2000 Nov; 87(10):937-45. PubMed ID: 11073891
[TBL] [Abstract][Full Text] [Related]
12. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
Sugiyama A; Okada M; Yamawaki H
Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
[TBL] [Abstract][Full Text] [Related]
14. Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells.
Asadi F; Razmi A; Dehpour AR; Shafiei M
J Pharm Pharmacol; 2016 Apr; 68(4):485-93. PubMed ID: 26945895
[TBL] [Abstract][Full Text] [Related]
15. Ca2+-dependent calcineurin/NFAT signaling in β-adrenergic-induced cardiac hypertrophy.
Khalilimeybodi A; Daneshmehr A; Sharif Kashani B
Gen Physiol Biophys; 2018 Jan; 37(1):41-56. PubMed ID: 29424351
[TBL] [Abstract][Full Text] [Related]
16. [Effects of hydrogen sulfide (H
Wu Y; Guo YY; Zhang YY; Zhang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
[TBL] [Abstract][Full Text] [Related]
17. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
18. Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin.
Pedram A; Razandi M; Lubahn D; Liu J; Vannan M; Levin ER
Endocrinology; 2008 Jul; 149(7):3361-9. PubMed ID: 18372323
[TBL] [Abstract][Full Text] [Related]
19. 17β-Estradiol and/or Estrogen Receptor β Attenuate the Autophagic and Apoptotic Effects Induced by Prolonged Hypoxia Through HIF-1α-Mediated BNIP3 and IGFBP-3 Signaling Blockage.
Hsieh DJ; Kuo WW; Lai YP; Shibu MA; Shen CY; Pai P; Yeh YL; Lin JY; Viswanadha VP; Huang CY
Cell Physiol Biochem; 2015; 36(1):274-84. PubMed ID: 25967966
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells.
Liu CJ; Cheng YC; Lee KW; Hsu HH; Chu CH; Tsai FJ; Tsai CH; Chu CY; Liu JY; Kuo WW; Huang CY
Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
